Fibrocell Science, Inc. Receives Gold Award for LAVIV™ from Prestigious 2012 Golden Bridge Awards Program
October 17 2012 - 8:00AM
Business Wire
Fibrocell Science, Inc. announced LAVIV™ (azficel-T) received
the prestigious Gold Award in the “Lifestyle, Beauty and Fashions”
Innovations category at the 4th Annual 2012 Golden Bridge Awards
program. According to the San Francisco based organization,
honorees are selected from an array of categories ranging from
individuals to Gadget Innovations, such as the iPad which also
received a Gold award. The awards were created to honor and
generate industry-wide recognition of the achievements and positive
contributions of organizations and businesses worldwide in every
area.
About Fibrocell Science, Inc.
Fibrocell Science, Inc. (OTCBB:FCSC.OB) is an autologous
cellular therapeutic company focused on the development of
innovative products for aesthetic, medical and scientific
applications. Fibrocell Science, Inc. is committed to advancing the
scientific, medical and commercial potential of autologous skin and
tissue, as well as its innovative cellular processing technology
and manufacturing excellence. For additional information, please
visit www.fibrocellscience.com.
About the Golden Bridge Awards
Golden Bridge Business and Innovation Awards are an annual
industry and peers recognition program honoring best companies in
every major industry from large to small and new start-ups in North
America, Europe, Middle-East, Africa, Asia-Pacific, and
Latin-America, Best New Products and Services, Best Innovations,
Management and Teams, Women in Business and the Professions, Case
Studies, Customer Satisfaction, and PR and Marketing Campaigns from
all over the world. Learn more about The Golden Bridge Awards at
www.goldenbridgeawards.com.